Showing results (241-250 of 1,698) with videos related to

Sort By:
Pageof 170
Gut and Liver|May 27, 2025
Early versus Late Eradication of Helicobacter pylori after Endoscopic Submucosal Dissection of Gastric Neoplasms: A Prospective, Multicenter, Randomized, Controlled StudyCheal Wung Huh, Da Hyun Jung, Jie-Hyun Kim, et al.
Gut and Liver|May 8, 2025
Gut-Liver Axis: The Role of Intestinal Microbiota and Their Metabolites in the Progression of Metabolic Dysfunction-Associated Steatotic Liver DiseaseChao Cui, Shuai Gao, Jingfei Shi, et al.
Gut and Liver|April 25, 2025
Sex Differences in the Effect of Changes in Body Mass Index on the Risk of Developing Gastric Cancer: Findings from a Nationwide Retrospective Cohort StudyJieun Jang, Yonghoon Choi, Nayoung Kim
Gut and Liver|April 21, 2025
Novel Risk Score for 30-Day Adverse Events Following Colonoscopy in Older AdultsMin-Jae Kim, Seoyoon Choi, Jihye Park, et al.
Gut and Liver|April 1, 2025
TEAD4 Transcriptionally Activates TRIB3 to Induce Ferroptosis Resistance through the MEK/ERK Signaling Pathway in Colorectal CancerJianguo Wang, Xiangbo Wu
Gut and Liver|April 1, 2025
Tumor Budding as an Additional Factor in Determining the Need for Surgery after Endoscopic Resection in Mucosal Invasive Gastric Cancer: A Retrospective Study from a Korean Tertiary HospitalYeonjin Je, Yuna Kim, Su-Jin Shin, et al.
Gut and Liver|April 1, 2025
Clinical Characteristics and Outcomes of Acute Mesenteric Ischemia in Young Adults: A KASID Multicenter StudySunghyeok Ryou, Kwangwoo Nam, Seong Ran Jeon, et al.
Gut and Liver|November 10, 2025
Prognostic Impact of Varices and Hemorrhagic Events in Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus BevacizumabJeayeon Park, Dong Ho Lee, Moon Haeng Hur, et al.
Gut and Liver|November 10, 2025
Establishing Epidemiological Cutoff Values for Helicobacter pylori Strains in Korea: A Model-Based Analysis of Antibiotic Resistance PatternsJin Hee Noh, Jung Mogg Kim, Hwoon-Yong Jung, et al.
Gut and Liver|September 17, 2025
Real-World Experience of Switching from Intravenous to Subcutaneous Vedolizumab in Korean Patients with Inflammatory Bowel DiseaseYu Kyung Jun, Yonghoon Choi, Cheol Min Shin, et al.
Pageof 170